Product Information

CAPTOPRIL 50 MG TABLET is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.4454 per EA under NDC 00143117310. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Feb 13, 1996. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CAPTOPRIL 50 MG TABLET

Captopril
$0.4454per EA

Strength

50 mg/1

NDC

00143117310

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

CAPTOPRIL

Approval Type

Generic (ANDA)

FDA Application

ANDA074505

FDA Approved

2/13/1996

TE Code

AB

On Market Since

2/13/1996

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors

Price Statistics

The NADAC for CAPTOPRIL 50 MG TABLET has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 42.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4454 per EA
All-time high$1.8234 (May 13, 2015)
All-time low$0.2326 (Oct 18, 2023)
52-week high$0.4454
52-week low$0.2335
Median price$1.0189
Average price$0.9624
Largest weekly change+134.2% (Aug 23, 2023)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+20.7%

3M

+43.8%

6M

+81.5%

1Y

+38.6%

3Y

+91.5%

5Y

-37.3%

All

-42.1%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 27% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CAPTOPRIL 50 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CAPTOPRIL 50 MG TABLET, manufactured by Hikma Pharmaceuticals USA Inc., is $0.4454 per EA (NDC 00143117310), effective Nov 11, 2026.

How has the price of CAPTOPRIL 50 MG TABLET changed over time?

Over the history we have for it, the NADAC for CAPTOPRIL 50 MG TABLET has declined 42.1%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CAPTOPRIL 50 MG TABLET?

Since Nov 28, 2013, the NADAC for CAPTOPRIL 50 MG TABLET has ranged from a low of $0.2326 (Oct 18, 2023) to a high of $1.8234 (May 13, 2015), with a median of $1.0189 per EA.

Are there cheaper alternatives to CAPTOPRIL 50 MG TABLET?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CAPTOPRIL 50 MG TABLET, is $0.3254 per EA — about 27% below CAPTOPRIL 50 MG TABLET.

Who manufactures CAPTOPRIL 50 MG TABLET?

CAPTOPRIL 50 MG TABLET (NDC 00143117310) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.